These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 28522038)
1. Injectable and topical neurotoxins in dermatology: Basic science, anatomy, and therapeutic agents. Giordano CN; Matarasso SL; Ozog DM J Am Acad Dermatol; 2017 Jun; 76(6):1013-1024. PubMed ID: 28522038 [TBL] [Abstract][Full Text] [Related]
2. Injectable and topical neurotoxins in dermatology: Indications, adverse events, and controversies. Giordano CN; Matarasso SL; Ozog DM J Am Acad Dermatol; 2017 Jun; 76(6):1027-1042. PubMed ID: 28522039 [TBL] [Abstract][Full Text] [Related]
3. The Use of Neurotoxins in the Male Face. Jones IT; Fabi SG Dermatol Clin; 2018 Jan; 36(1):29-42. PubMed ID: 29108543 [TBL] [Abstract][Full Text] [Related]
4. New neurotoxins on the horizon. Freeman SR; Cohen JL Aesthet Surg J; 2008; 28(3):325-30. PubMed ID: 19083544 [TBL] [Abstract][Full Text] [Related]
5. Botulinum neurotoxin type A-ABO (Dysport): clinical indications and practice guide. Matarasso A; Shafer D Aesthet Surg J; 2009 Nov; 29(6 Suppl):S72-9. PubMed ID: 19945008 [TBL] [Abstract][Full Text] [Related]
6. Update on botulinum neurotoxin use in aesthetic dermatology. Ibrahim O; Keller EC; Arndt KA Semin Cutan Med Surg; 2014 Dec; 33(4):152-6. PubMed ID: 25830246 [TBL] [Abstract][Full Text] [Related]
8. Botulinum neurotoxin type B--a rapid wrinkle reducer. Jacob CI Semin Cutan Med Surg; 2003 Jun; 22(2):131-5. PubMed ID: 12877232 [TBL] [Abstract][Full Text] [Related]
9. Botulinum neurotoxin: the ugly duckling. Koussoulakos S Eur Neurol; 2009; 61(6):331-42. PubMed ID: 19365125 [TBL] [Abstract][Full Text] [Related]
10. Advancements and Refinement in Facial Neuromodulators. Kordestani R; Small KH; Rohrich RJ Plast Reconstr Surg; 2016 Oct; 138(4):803-806. PubMed ID: 27673516 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products. Dessy LA; Fallico N; Mazzocchi M; Scuderi N Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763 [TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type B: a new injectable treatment for cervical dystonia. Brashear A Expert Opin Investig Drugs; 2001 Dec; 10(12):2191-9. PubMed ID: 11772315 [TBL] [Abstract][Full Text] [Related]
13. Botulinum Toxin in the Field of Dermatology: Novel Indications. Kim YS; Hong ES; Kim HS Toxins (Basel); 2017 Dec; 9(12):. PubMed ID: 29258169 [TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin: examining duration of effect in facial aesthetic applications. Flynn TC Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902 [TBL] [Abstract][Full Text] [Related]
15. Injectable Cosmetic Procedures for the Male Patient. Wieczorek IT; Hibler BP; Rossi AM J Drugs Dermatol; 2015 Sep; 14(9):1043-51. PubMed ID: 26355626 [TBL] [Abstract][Full Text] [Related]
16. The convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine--a global, evidence-based botulinum toxin consensus education initiative: part I: botulinum toxin in clinical and cosmetic practice. Carruthers A; Kane MA; Flynn TC; Huang P; Kim SD; Solish N; Kaeuper G Dermatol Surg; 2013 Mar; 39(3 Pt 2):493-509. PubMed ID: 23458294 [TBL] [Abstract][Full Text] [Related]
17. S1 guideline aesthetic botulinum toxin therapy. Imhof M; Podda M; Sommer B; ; J Dtsch Dermatol Ges; 2013 Oct; 11(10):e1-13. PubMed ID: 26227365 [No Abstract] [Full Text] [Related]
18. Injection technique in neurotoxins and fillers: Indications, products, and outcomes. Alam M; Tung R J Am Acad Dermatol; 2018 Sep; 79(3):423-435. PubMed ID: 30119866 [TBL] [Abstract][Full Text] [Related]
19. The Potential Role of Botulinum Toxin in Improving Superficial Cutaneous Scarring: A Review. Dhawan A; Dhawan S; Vitarella D J Drugs Dermatol; 2018 Sep; 17(9):956-958. PubMed ID: 30235381 [TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin: application, safety, and limitations. Bigalke H Curr Top Microbiol Immunol; 2013; 364():307-17. PubMed ID: 23239359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]